About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 325 record(s)
Req # 1025-2020-014535
Please provide in spreadsheet form the total amount of expenses incurred between March 1st 2020 and the date on which this request is received detailing all expenses with the 2020/2021 object codes 1231, 1246, and 0533. Provide a breakdown of expenses incurred, provide the name of the service provider/contractor, a description of service rendered, the date, and the total amount of the expense. When this data does not exist in the aforementioned format, provide receipts, purchase orders and service contracts pertaining to the expense. Search through electronic records only, unless data is not available in that format. Remove French versions of records if English ones exist. Provide the final version of documents or last draft if the final version is not available.Organization: Financial Consumer Agency of Canada
September 2020
Req # A-2020-00004
List of mandatory or voluntary training, info sessions, awareness sessions, and sensitivity training from January 1, 2020 to September 2020.Organization: Patented Medicine Prices Review Board Canada
September 2020
Req # A-2020-04135
Copies of the Human Drug Advisory (HDAP) report for erenumab (Aimovig) from January 2018 to February 2020.Organization: Patented Medicine Prices Review Board Canada
September 2020
Req # A-2020-09098
Copies of all records discussing the impacts of the regulatory changes to the PMPRB from August 2019 until August 2020. Copies of all correspondence from all pharmaceutical companies expressing their concerns with the changes and any responses back to these companies. Copies of all correspondence from all advocating groups expressing concerns with the changes and any responses back to these groups. Copies of all correspondence between departmental staff discussing the impacts of the regulatory changes to the PMPRB. Copies of all records discussing the impacts of the PMPRB changes on individuals living with rare diseases. Copies of all correspondence from Vertex Pharmaceuticals relating to Kalydeco, Orkambi, Symdeko, and Trikafta. Copies of all correspondence between government officials (Prime Minister, Ministers, all members of parliament, constituency staff, deputies, assistant deputies, directors, managers, supervisors, staff, and any other employee of the Government of Canada relating to the PMPRB regulatory changes. Copies of all presentations relating to the PMPRB regulatory changes.Organization: Patented Medicine Prices Review Board Canada
September 2020
Nothing to report this month
Organization: RCMP External Review Committee
Req # 1025-2020-012534
All drafts of the FCAC report dated March 20, 2018 on Domestic Bank Retail Sales Practices Review sent to the Department of Finance or to Canadian banks, and all correspondence exchanged between FCAC, OSFI, banks, and/or the Department of Finance in connection with the Domestic Bank Retail Sales Practices Review, between February 1, 2017 and December March 20, 2018.Organization: Financial Consumer Agency of Canada
August 2020
Req # 1025-2020-012537
All FCAC records, documents, and correspondence related to "sales practices" at banks and/or a review of "business practices", including correspondence between OSFI and the FCAC, and/or the Department of Finance, between February 1, 2017 and March 20, 2018. All FCAC records documents and correspondence related to ʺsales practices at banks and/or a review or examination of ʺbusiness practices mentioning Toronto-Dominion Bank (TD), or exchanged with TD, between February 1, 2017 and March 20, 2018.Organization: Financial Consumer Agency of Canada
August 2020
Req # A-2020-01436
Copies of reports, discussions, briefings, memos and decisions related to the introductory price review for erenumab (Aimovig) from January 2018 to February 2020.Organization: Patented Medicine Prices Review Board Canada
August 2020
Req # A-2020-04137
Copies of the PMPRB documentation related to the scientific review and pricing review of erenumab (Aimovig) from January 2018 to February 2020.Organization: Patented Medicine Prices Review Board Canada
August 2020
Nothing to report this month
Organization: RCMP External Review Committee